In patients with type 2 diabetes inadequately controlled with metformin, adding a novel nonpeptide oral GLP-1 receptor agonist to metformin boosts glycemic control.

New studies suggest oral GLP-1 drugs may curb food cravings through unique brain pathways and could help treat alcohol use disorder.

Lower-cost access to certain weight loss drugs may help more Medicare enrollees, but experts urge careful conversations about interactions, dehydration and other concerns.

Discover the top 16 websites for buying GLP-1 weight loss medications online. Our expert-reviewed guide helps you find safe ...

LLY beat Q1 EPS estimates by 26% and launched Foundayo, while beaten-down NVO trades near 10x earnings and 45% below its 52-week high. Viking's pre-revenue VKTX carries binary Phase 3 risk, but VK2735 ...

Yale University researchers were able to easily obtain GLP-1 prescriptions online using fake patient profiles, in some instances receiving prescriptions in less than five minutes and with minimal ...

A record number of Americans are taking GLP-1 drugs for weight loss, according to a new Gallup survey released Tuesday — a massive increase over the past two years. According to the poll, 11 percent ...

Phase 3 trials of Kailera Therapeutics’ oral GLP-1 prospect have hit their primary endpoints, positioning the biotech’s partner Hengrui Pharma to seek approval in obesity and diabetes in China.

Popular GLP-1 weight-loss drugs are becoming much more affordable for millions of older adults starting Wednesday, July 1, as Medicare begins to cover them — for now. The Medicare GLP-1 Bridge is a ...

Viking Therapeutics, Inc. maintains a Hold rating, reflecting a balanced risk-reward at its current ~$5B valuation amid sector momentum. Novo Nordisk’s oral Wegovy launch sets a new benchmark, ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Some Medicare patients will be able to access to GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more ...